Study limitation: The 'practice changing' impact flag is applied cautiously — this is a phase 2 trial with a small analysed sample (n=43); findings should be considered preliminary pending phase 3 replication | ReachRx
Improvement in neuropsychological function with memantine treatment among patients with systemic lupus erythematosus: a phase 2 randomised placebo-controlled clinical trial
Study limitation reported by the research below: “The 'practice changing' impact flag is applied cautiously — this is a phase 2 trial with a small analysed sample (n=43); findings should be considered preliminary pending phase 3 replication.”
